

Tom's Blog on Life and Livingness

First of all, in a leaked recording, it was revealed that the soups contained lab-grown meat – or “chicken that came from a 3-D printer.” Campbell’s strenuously refutes this comment, though the company does use genetically modified ingredients such as canola, corn, soybeans, and sugar beets.
And, just in case that accusation wasn’t enough to make your guts gurgle, it isn’t even the worst thing on that recording.
Robert Garza, a cybersecurity analyst for the company, was meeting at a restaurant with Martin Bally, one of Campbell’s vice presidents, to discuss his salary.
He secretly recorded statements made by the VP and chief information security officer during a November 2024 meeting. In a rant that lasted over an hour, here are some of the things captured on the recording.
Local 4 News in Detroit broadcast portions of the recording. In it, a speaker identified as Bally is heard saying, “We have s**t for f***king poor people. Who buys our s**t? I don’t buy Campbell’s products barely anymore. It’s not healthy now that I know what the f**‘s in it.”
He also referenced “bioengineered meat,” saying, “I don’t wanna eat a piece of chicken that came from a 3D printer.”
https://www.zerohedge.com/medical/campbells-vp-admits-soup-st-fking-poor-people-chicken-3d-printer
(Tom: Jack Lalanne famously said, “If man made it, don’t eat it.” The longer I live the more examples I see of the truth of what Jack said and the more I value what I make myself.)


Landmark analysis identifies 12 natural compounds with broad anti-cancer activity, consistently targeting core pathways such as cell death, immune evasion, metabolic dysfunction, and metastasis.
A landmark 2025 review titled, Natural anti-cancer products: insights from herbal medicine, published in Chinese Medicine, pulled together more than 1,100 scientific studies and uncovered something extraordinary: across cell, animal, and multi-omics research, 12 natural compounds repeatedly showed potent anti-cancer activity—triggering cancer cell death, blocking metastasis, cutting off tumor blood supply, disrupting tumor metabolism, and reversing drug resistance. Notably, the vast majority of this evidence comes from studies published since 2019, reflecting a rapid surge of new research in this field.
Landmark analysis identifies 12 natural compounds with broad anti-cancer activity, consistently targeting core pathways such as cell death, immune evasion, metabolic dysfunction, and metastasis.
Helps immune cells detect tumors (reduces PD-L1)
Slows growth signals inside cancer cells (inhibits PI3K/AKT, EGFR, ERK)
Improves chemotherapy responsiveness (reduces MDR1/P-gp activity)
Limits tissue invasion (suppresses NF-?B, MMP-2/9)
Induces cell death through several pathways (apoptosis, autophagy, ferroptosis)
Generates oxidative stress inside tumors (ROS, lipid peroxidation)
Restricts blood vessel formation (anti-angiogenic)
Slows cancer cell movement (reduces vimentin, N-cadherin)
Helps counter drug resistance (affects STAT3, AKT, HSP90)
Shows activity across many animal tumor models
Disrupts major growth pathways (PI3K/AKT, HER2, TGF-ß)
Reduces tumor-fueling inflammation (NF-?B)
Helps reverse drug resistance (P-gp, MRP1, NRF2)
Lowers immune evasion signals (PD-L1)
Reduces metastatic behavior (MMP-2/9)
Triggers cancer cell death (apoptosis, autophagy, ferroptosis)
Lowers inflammation inside tumors (NF-?B, STAT3)
Blocks blood vessel growth (VEGF inhibition)
Helps reverse chemotherapy resistance (P-gp, BCRP)
Reduces invasive behavior (Twist1, MMP-9, EMT markers)
Interferes with cancer cell communication (Wnt/ß-catenin, STAT3, NF-?B)
Initiates several types of cell death (necroptosis, ferroptosis)
Disrupts cancer metabolism (GLUT1 reduction)
Limits spread by reducing enzymes that break tissue barriers (MMP-2/9)
Helps counter drug resistance (P-gp, GST)
Slows growth by interrupting major pathways (PI3K/AKT/mTOR)
Promotes programmed cell death (Bax?, Bcl-2?)
Reduces inflammation (STAT3)
Inhibits invasion and angiogenesis (MMP-2/9, VEGF)
Decreases drug resistance (P-gp suppression)
Reduce metastatic behavior (EMT inhibition, MMP suppression)
Improve immune responses (STAT3 downregulation)
Promote cancer cell death (caspase activation)
Help restore normal growth regulation (p53, PTEN)
Some forms influence gut microbiota related to tumor microenvironments
Support immune recognition of tumors (CD8+ T cells, CXCL9/10)
Reduce PD-L1 (a key shield tumors use to hide)
Inhibit tumor growth signals (PI3K/AKT)
Counteract chemotherapy resistance (P-gp, MRP1)
Improve cell adhesion and reduce invasiveness (E-cadherin upregulation)
Activates protective genes (p53)
Reduces inflammation (NF-?B)
Slows invasive behavior (vimentin?, EMT?)
Initiates multiple cell death pathways (apoptosis, autophagy, ferroptosis)
Shows synergy with conventional treatments
Slows growth signals (mTOR, STAT3)
Reduces tumor blood vessel development (anti-angiogenic)
Limits spread (Wnt/ß-catenin inhibition)
Supports mitochondrial function
Decreases PD-L1 expression
Very potent at low concentrations (nanomolar range)
Blocks multiple tumor-promoting pathways (NF-?B, STAT3, AKT/mTOR)
Lowers immune evasion signals (PD-L1, CD47)
Promotes apoptosis and cell-cycle arrest
Promotes cell death pathways (p53, ROS)
Slows tumor growth (AKT/mTOR inhibition)
Limits metastatic movement (CXCL12, FN1)
Helps reduce drug resistance
Activates stress pathways related to ferroptosis (NRF2 suppression)
Although the review does not provide detailed clinical trial outcomes, it assembles one of the most comprehensive collections of preclinical evidence ever compiled on how natural compounds act on cancer. Across cell studies, xenograft models, orthotopic tumors, and multi-omics analyses, the findings converge on a striking pattern: these molecules consistently disrupt the same core pathways that fuel tumor growth, immune evasion, metastasis, and treatment resistance.
Importantly, several of these compounds—such as curcumin, artemisinin derivatives, ginsenosides, icaritin, silibinin, and resveratrol—are no longer confined to laboratory research. Multiple early-stage and mid-stage clinical trials are already underway, and in the case of icaritin and certain ginsenosides, Phase II and Phase III studies are actively progressing. The scientific community is clearly beginning to take notice.
With cancer rates rising worldwide, these well-tolerated, multi-pathway natural compounds should be advanced into rigorous clinical testing to fully determine their therapeutic potential in human disease.
Source: https://www.thefocalpoints.com/p/over-1100-studies-reveal-12-natural
The SARS-CoV-2 virus, responsible for COVID-19, owes much of its pathogenicity to its Spike protein—a multifunctional structure that facilitates viral entry into host cells via ACE2 receptors. While the acute effects of COVID-19 have been widely studied, emerging evidence suggests that the Spike protein’s persistence in human tissues may have profound long-term consequences, potentially reducing human longevity. COVID-19 vaccination with mRNA or adenoviral DNA appears to be far worse than infection in terms of loading the body with Spike protein, which is full-length in the prefusion conformation, trimerized, and highly pathogenic.
(Tom: This destructive action of the Spike Protein is why I have created a combination of the ingredients reputed or proven to benefit those suffering from Spike Protein damage. Read more about it here: https://www.healthelicious.com.au/NutriBlast-Anti-Spike.html)
https://www.thefocalpoints.com/p/why-the-sars-cov-2-spike-protein
Maria and I also confronted the deeper question: Why have health agencies done nothing? Top officials at HHS have been repeatedly notified of these findings, yet they refuse to act.
Their silence keeps millions in harm’s way while the shots continue — and while zero funding goes toward identifying or treating this new pathology.
In my interview with Maria Zeee on the Daily Pulse, we walked through what is now shaping up to be one of the most urgent and ignored public health emergencies of the post-COVID era.
These misfolded fibrin clots are structurally abnormal, resistant to normal breakdown, and capable of accumulating inflammatory molecules, DNA, and other debris. They are likely also behind the long, rubbery, white fibrous clots that embalmers are pulling out of bodies worldwide.
https://open.substack.com/pub/petermcculloughmd/p/breakthrough-nattokinase-experimentally
Jarle’s analysis identifies a statistically significant demographic anomaly consistent with other early-warning fertility signals. This should be investigated, not ignored.
CDC data from 566 US counties, with a combined population of nearly 260 million, show that COVID-19 vaccination in 2023 was significantly linked to fewer live births. Extrapolating these findings to the entire US population estimates 69,598 fewer births (95% CI: -111,215; -27,981), representing a 1.90 percent reduction (95% CI: -3.01; -.785). Additionally, the vaccine was linked to fewer births in 2022, but the association was not statistically significant that year.
In a previous post, I showed that COVID-19 vaccination caused over 138,000 US deaths in 2022 and over 150,000 in 2023. Hence, COVID-19 vaccination has decimated the US population by increasing deaths and decreasing births, which follow-up research should explain.
A concern beyond what I described above is that the vaccine seems to have induced an increasing trend in deaths and a decreasing trend in births, which follow-up research should monitor and eventually also explain.
Finish reading: https://open.substack.com/pub/jarle/p/covid-19-vaccination-was-linked-to

I received an emailed ad for a new product that contains some data I had not seen before. Took me down an interesting path of discovery about which I will share more later.
Here is some of the ad and a link to the rest of it:
Discover the groundbreaking “phage” technology that succeeds where probiotics and restrictive diets fail – and can target bloating, constipation, and digestive distress in just hours.
If you’re like most people with chronic bloating, constipation, or other digestive woes, you’ve probably been told that probiotics are the answer.
Just flood your gut with “good bacteria,” they say, and watch your symptoms disappear.
But what if I told you that probiotics are not the gut-healing cure-all they’re cracked up to be?
In fact, for some people, they can actually make digestive issues worse.
The truth is, when it comes to lasting relief from gut distress, adding more bacteria – even the “good” kind – is like trying to weed an overgrown garden by planting more flowers.
It doesn’t directly address the root of the problem.
So what does?
Cutting-edge research has revealed a remarkable new approach that succeeds where probiotics and restrictive diets fail.
It’s called bacteriophage therapy, and it’s based on a simple but profound idea:
Instead of just adding more bacteria to your gut, what if you could precisely target and eliminate the “bad guys” causing all the trouble?
https://start.goodnesslover.com/bacteriophage-article-probiotics-25blackfriday/
